| Bioactivity | Talampanel (LY300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor antagonis with anti-seizure activity[1]. Talampanel (IVAX) has neuroprotective effects in rodent stroke models[2]. Talampanel attenuates caspase-3 dependent apoptosis in mouse brain[2]. | ||||||||||||
| Name | Talampanel | ||||||||||||
| CAS | 161832-65-1 | ||||||||||||
| Formula | C19H19N3O3 | ||||||||||||
| Molar Mass | 337.37 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Talampanel
CAS: 161832-65-1 F: C19H19N3O3 W: 337.37
Talampanel (LY300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor antag
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.